where CD5-2 was demonstrated to normalize tumor vessels (increased VE-Cadherin, reduced hypoxia, reduced permeability, increased pericyte coverage) in MC38 (colon cancer cell line) and B16F10 (melanoma cell line) isograft tumors (12). The gene discussed is CDH5; the disease is melanoma.